Low‐Density Lipoprotein Cholesterol and Mortality in Older People

Objectives: To investigate the role of low‐density lipoprotein cholesterol (LDL‐C) as a predictor of mortality in elderly subjects.

[1]  R. Mayeux,et al.  Relationship Between Plasma Lipids and All‐Cause Mortality in Nondemented Elderly , 2005, Journal of the American Geriatrics Society.

[2]  T. Lumley,et al.  The Association Between Lipid Levels and the Risks of Incident Myocardial Infarction, Stroke, and Total Mortality: The Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.

[3]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[4]  P. Whincup,et al.  Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. , 2003, European heart journal.

[5]  D. Inzitari,et al.  Low Total Cholesterol and Increased Risk of Dying: Are Low Levels Clinical Warning Signs in the Elderly? Results from the Italian Longitudinal Study on Aging , 2003, Journal of the American Geriatrics Society.

[6]  R. Collins,et al.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.

[7]  J. Shepherd,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial , 2003 .

[8]  H. Ueshima,et al.  What cause of mortality can we predict by cholesterol screening in the Japanese general population? , 2003, Journal of internal medicine.

[9]  Barry R. Davis,et al.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). , 2002, JAMA.

[10]  Y. Friedlander,et al.  Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. , 2001, Atherosclerosis.

[11]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.

[12]  A. Bayer,et al.  Age and gender bias in statin trials. , 2001, QJM : monthly journal of the Association of Physicians.

[13]  A. Nissinen,et al.  Total but not high-density lipoprotein cholesterol is consistently associated with coronary heart disease mortality in elderly men in Finland, Italy, and The Netherlands. , 2000, Epidemiology.

[14]  HOMAS,et al.  The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .

[15]  Ames,et al.  PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .

[16]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[17]  W. Kannel,et al.  Cardiovascular risk factors in the elderly , 1997, Coronary artery disease.

[18]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[19]  H. Krumholz,et al.  Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. , 1994, JAMA.

[20]  W. L. Ooi,et al.  Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  T. Manolio,et al.  Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. , 1992, Annals of epidemiology.

[22]  E. Casiglia,et al.  The CASTEL project (CArdiovascular STudy in the ELderly): protocol, study design, and preliminary results of the initial survey. , 1991, Cardiologia.

[23]  C. Bulpitt,et al.  Is a high serum cholesterol level associated with longer survival in elderly hypertensives? , 1990, Journal of hypertension.

[24]  D. Reed,et al.  Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? , 1990, JAMA.

[25]  J. Hainer.  Cholesterol and mortality. , 1987, JAMA.

[26]  D. Levy,et al.  Cholesterol and mortality. 30 years of follow-up from the Framingham study. , 1987, JAMA.

[27]  W. Browner,et al.  SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY , 1987, The Lancet.

[28]  L. Kuller,et al.  SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.

[29]  J. G. Evans,et al.  The epidemiology of stroke. , 1979, Age and ageing.

[30]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[31]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.